Literature DB >> 9428609

DNA topoisomerase I: customs officer at the border between DNA and RNA worlds?

J Tazi1, F Rossi, E Labourier, I Gallouzi, C Brunel, E Antoine.   

Abstract

DNA topoisomerase I is required for the normal development of multicellular organisms, probably because it plays a role in controlling gene activity, in addition to its function in relieving tortional stress during DNA replication and transcription. The discovery of DNA topoisomerase I as a specific kinase that phosphorylates serine-arginine rich (SR) splicing factors may provide new insights into their precise function in regulating gene expression. It is clear that the splicing factors phosphorylated by DNA topoisomerase I can modulate gene expression by changing the splicing pattern of structural genes. Studies of the splicing mechanism suggest that the phosphorylation of serine residues of SR proteins contribute to their activity. As this phosphorylation can be accomplished by several kinases, it remains to be determined whether phosphorylation by DNA topoisomerase I protein kinase is the limiting step in regulating this process. The availability of specific inhibitors of DNA topoisomerase I, structurally related to the alkaloid camptothecin, have made it possible to address this question experimentally. These inhibitors, which hold great promise as antineoplastic drugs, lead to specific inhibition of SR protein phosphorylation in cultured cells. This observation will hopefully lead to improved understanding of the mechanism by which these drugs act at cellular level.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9428609     DOI: 10.1007/s001090050168

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  11 in total

1.  The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53.

Authors:  C Gobert; A Skladanowski; A K Larsen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

2.  Genome-wide analysis of novel splice variants induced by topoisomerase I poisoning shows preferential occurrence in genes encoding splicing factors.

Authors:  Stéphanie Solier; Jennifer Barb; Barry R Zeeberg; Sudhir Varma; Mike C Ryan; Kurt W Kohn; John N Weinstein; Peter J Munson; Yves Pommier
Journal:  Cancer Res       Date:  2010-09-03       Impact factor: 12.701

3.  Identification of small molecule and genetic modulators of AON-induced dystrophin exon skipping by high-throughput screening.

Authors:  Debra A O'Leary; Orzala Sharif; Paul Anderson; Buu Tu; Genevieve Welch; Yingyao Zhou; Jeremy S Caldwell; Ingo H Engels; Achim Brinker
Journal:  PLoS One       Date:  2009-12-17       Impact factor: 3.240

4.  A conserved Drosophila transportin-serine/arginine-rich (SR) protein permits nuclear import of Drosophila SR protein splicing factors and their antagonist repressor splicing factor 1.

Authors:  Eric Allemand; Svetlana Dokudovskaya; Rémy Bordonné; Jamal Tazi
Journal:  Mol Biol Cell       Date:  2002-07       Impact factor: 4.138

5.  The C-terminal domain but not the tyrosine 723 of human DNA topoisomerase I active site contributes to kinase activity.

Authors:  F Rossi; E Labourier; I E Gallouzi; J Derancourt; E Allemand; G Divita; J Tazi
Journal:  Nucleic Acids Res       Date:  1998-06-15       Impact factor: 16.971

6.  Distinctive features of Drosophila alternative splicing factor RS domain: implication for specific phosphorylation, shuttling, and splicing activation.

Authors:  E Allemand; R Gattoni; H M Bourbon; J Stevenin; J F Cáceres; J Soret; J Tazi
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

7.  The SR protein B52/SRp55 is required for DNA topoisomerase I recruitment to chromatin, mRNA release and transcription shutdown.

Authors:  François Juge; Céline Fernando; Weronika Fic; Jamal Tazi
Journal:  PLoS Genet       Date:  2010-09-16       Impact factor: 5.917

8.  Mob2 Insufficiency Disrupts Neuronal Migration in the Developing Cortex.

Authors:  Adam C O'Neill; Christina Kyrousi; Melanie Einsiedler; Ingo Burtscher; Micha Drukker; David M Markie; Edwin P Kirk; Magdalena Götz; Stephen P Robertson; Silvia Cappello
Journal:  Front Cell Neurosci       Date:  2018-03-12       Impact factor: 5.505

9.  CKD-602, a topoisomerase I inhibitor, induces apoptosis and cell-cycle arrest and inhibits invasion in cervical cancer.

Authors:  Sungha Lee; Jung Yoon Ho; Jing Jing Liu; Hyewon Lee; Jae Young Park; Minwha Baik; Minji Ko; Seon Ui Lee; Youn Jin Choi; Soo Young Hur
Journal:  Mol Med       Date:  2019-05-28       Impact factor: 6.354

10.  Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin is p53-independent.

Authors:  Chia-Yen Wu; Ilsa Gómez-Curet; Vicky L Funanage; Mena Scavina; Wenlan Wang
Journal:  BMC Cell Biol       Date:  2009-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.